CJ-033466 25 mg | ≥98% Cayman Chemical A 5-HT4 receptor partial agonist More Information Supplier Page × CJ-033466
CJ-033466 10 mg | ≥98% Cayman Chemical A 5-HT4 receptor partial agonist More Information Supplier Page × CJ-033466
CJ-033466 1 mg | ≥98% Cayman Chemical A 5-HT4 receptor partial agonist More Information Supplier Page × CJ-033466
AMG 009 50 mg | ≥98% Cayman Chemical A DP2/CRTH2 and DP1 dual antagonist More Information Supplier Page × AMG 009
AMG 009 5 mg | ≥98% Cayman Chemical A DP2/CRTH2 and DP1 dual antagonist More Information Supplier Page × AMG 009
AMG 009 100 mg | ≥98% Cayman Chemical A DP2/CRTH2 and DP1 dual antagonist More Information Supplier Page × AMG 009
AMG 009 10 mg | ≥98% Cayman Chemical A DP2/CRTH2 and DP1 dual antagonist More Information Supplier Page × AMG 009
Ralaniten 50 mg | ≥95% Cayman Chemical An antagonist of the androgen receptor NTD More Information Supplier Page × Ralaniten
Ralaniten 5 mg | ≥95% Cayman Chemical An antagonist of the androgen receptor NTD More Information Supplier Page × Ralaniten
Ralaniten 25 mg | ≥95% Cayman Chemical An antagonist of the androgen receptor NTD More Information Supplier Page × Ralaniten
